IE 11 is a very old browser and is not supported on this site.

12. Discontinued operations 

On 30 March 2023 Galenica announced the combination of the business activities of the specialty pharmacy Mediservice Ltd. (including Curarex swiss AG) and the online pharmacy redcare-apotheke.ch  in a strategic partnership with Redcare Pharmacy N.V. The closing of the transaction occurred on 16 May 2023.

Through the transaction, Galenica sold 51% of the shares of Mediservice Ltd. to Redcare Pharmacy N.V. The total purchase consideration amounted to CHF 215.5 million, consisting of a 6.1% investment in the listed company Redcare Pharmacy N.V., Netherlands with a fair value of CHF 109.5 million and the retained 49% participation in Mediservice Ltd. (including the online pharmacy shop-apotheke.ch) with a fair value of CHF 106.0 million. The remaining 49% participation in Mediservice Ltd. is accounted for as an investment in an associate.

At the date of disposal, the purchase consideration was reduced by an estimated amount of CHF 10.6 million which is contingent on net working capital developments as well as certain market developments and will become due between 2024 and 2027. In 2024 the remeasurement of the contingent consideration liability resulted in a change in fair value of minus CHF 0.1 million (previous year: CHF 7.7 million) which was allocated to the net profit from discontinued operations.

Gain on sale of discontinued operations

in thousand CHF

2024

2023

Fair value of received equity instruments

109,456

Fair value of retained at equity investment in former subsidiary

106,011

Contingent considerations

–10,594

Total considerations received / interest retained

204,873

 

 

 

Carrying amount of net assets disposed

–86,776

Transaction costs

–813

Income taxes related to the sale of the discontinued operations

–5,515

 

 

 

Gain on sale of discontinued operations as per date of disposal

111,769

 

 

 

Net remeasurement of change in fair value of contingent consideration liabilities related to sale of discontinued operations

–80

7,663

Gain on sale of discontinued operations

–80

119,432

The table below shows the financial performance of the discontinued operations in the previous year.

Statement of income of discontinued operations

in thousand CHF

1.1.– 16.5.2023

Net sales

164,487

Other income

18

Expenses

–163,238

Earnings before tax (EBT) from discontinued operations

1,266

 

 

Income taxes

–251

 

 

Net profit from discontinued operations

1,015

Accounting principles discontinued operations

A disposal group is classified as a discontinued operation if it represents a separate major line of business or geographical business unit. Discontinued operations are not included in the result from continuing operations and are reported separately in the consolidated statement of income as profit from discontinued operations. The prior period amounts in the income statement and in the consolidated statement of cash flows are adjusted for comparison purposes. The elimination of intercompany transactions between continuing and discontinued operations is adjusted in order to reflect the impact of these transactions in continuing operations going forward. Therefore, intercompany transactions with the discontinued operations are treated as third parties transaction in the continuing operation.

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer